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Abstract.  The influence of J1/tenascin adsorbed to 
polyornithine-conditioned plastic (substrate-bound 
J1/tenascin) and J1/tenascin present in the culture 
medium (soluble J1/tenascin) on neurite outgrowth was 
studied with cultured single cells from hippocampus 
and mesencephalon of embryonic rats.  Neurons at low 
density grew well on J1/tenascin substrates and ex- 
tended neurites that were ~40%  longer than on the 
polyornithine control substrate after 24 h in vitro.  The 
neurite outgrowth promoting effect of substrate bound 
J1/tenascin was largely abolished in the presence of 
mAb J1/tn2,  but not by mAb J1/tnl.  In contrast to the 
neurite growth-promoting effects of substrate bound 
J1/tenascin,  neurite outgrowth on polyornithine, lami- 
nin,  fibronectin, or J1/tenascin as substrates was in- 
hibited by addition of soluble J1/tenascin to the cul- 
tures.  Neither of the two rnAbs neutralized the neurite 
outgrowth-inhibitory properties of soluble J1/tenascin. 
In contrast to their opposite effects on neurite out- 
growth, both substrate-bound and soluble J1/tenascin 
reduced spreading of the neuronal cell bodies, suggest- 
ing that the neurite outgrowth-promoting and anti- 
spreading effects are mediated by two different sites on 
the molecule.  This was further supported by the in- 
ability of the rnAb J1/tn2  to neutralize the antispread- 
ing effect. The J1/tn2  epitope localizes to a fibronectin 
type III homology domain that is presumably distinct 
from the putative Tn68 cell-binding domain of chicken 
tenascin for fibroblasts, as shown by electronmicro- 
scopic localization of antibody binding sites. We infer 
from these experiments that Jl/tenascin contains a neu- 
rite outgrowth promoting domain that is distinguish- 
able from the cell-binding site and presumably not in- 
volved in the inhibition of neurite outgrowth or cell 
spreading.  Our observations support the notion that 
J1/tenascin is a multi  functional extracellular matrix 
molecule. 
T 
He Jl-glycoproteins of 160- and 180-kD  01-160/180) 
and 200- and 220-kD (J1-200/220)  apparent  molec- 
ular weights were originally described as constituents 
of the L2/HNK-1  family of neural cell adhesion molecules 
(Kruse et al.,  1984,  1985).  Polyclonal J1 antibodies local- 
ized the Jl-glycoproteins to the surface of glial cells and in- 
hibited the binding of small cerebeUar neurons to astrocyte 
monolayers in vitro (Kruse et al., 1985). Subsequent studies 
with specific mono- and polyclonal antibodies have shown 
that J1-160/180 and J1-200/220 have to be considered as two 
independent molecular pairs which share a small, but detect- 
able degree of homology (Faissner et al.,  1988; Pesheva et 
al.,  1989; Falssner and Kruse,  1990).  J1-160/180 is an ex- 
tracellular  matrix  molecule associated  with  oligodendro- 
cytes in postnatal mouse central nervous system (Pesheva et 
al., 1989) and is involved in neuron-oligodendrocyte and as- 
trocyte--oligodendrocyte interactions  (Morganti et al., 1990). 
As substrate in mixture with laminin purified J1-160/180 in- 
terferes with attachment and neurite outgrowth of cerebellar 
granule cells (Pesheva et al.,  1989). 
J1-200/220 is the mouse equivalent of tenascin, previously 
designated myotendinous antigen (Chiquet and Fambrough, 
1984a,b; Chiquet-Ehrismann  et al.,  1986) as revealed im- 
munochemically and by primary sequence analysis (Faissner 
et al.,  1988; WeUer et al.,  1991). It belongs to a group of 
extraceUular  matrix (ECM)  ~ molecules which includes the 
hexabrachion  (Erickson and Inglesias,  1984), glioma mesen- 
chymal extraceUular matrix antigen (Bourdon et al., 1985), 
cytotactin (Grumet et al.,  1985), and polypeptide 150/225 
(Gulcher et al., 1986). Tenascin and related molecules form 
multimers linked by NH2-terminal disulfide bridges thereby 
creating  the so-called T-junction  (Erickson and Inglesias, 
1984).  Molecular  genetic  investigations  have  shown  that 
1. Abbreviations used in this paper: ECM, extracellular matrix; N-CAM, 
neural cell adhesion molecule. 
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isoforms which contain variable numbers of fibronectin type 
HI repeats, a motive  originally  described in fibronectin (Peter- 
sen et al., 1983),  a cystein-rich aminoterminal domain fol- 
lowed by 13.5 EGF-like repeats,  a motive also present in 
laminin (Sasaki and Yamada, 1987; Sasaki et al., 1987), and 
a carboxyterminal  fibrinogen  homology  domain (Jones et al., 
1989; Spring et al., 1989). The human hexabrachion displays 
~80% homology to chicken tenascin (Gulcher et al., 1989). 
Jl/tenascin exhibits a site- and time-restricted expression 
in various developing organs. It displays different functional 
properties when isolated from developing mesenchymal and 
neuroectodermal sources  (Faissner  et  al.,  1990;  Probst- 
meier et al., 1990) and is barely detectable in the adult tis- 
sues  investigated (for review see  Erickson and Bourdon, 
1989).  J1/tenascin  is synthesized by cultured astrocytes and 
Schwann cells (Kruse et al.,  1985;  Faissner et al.,  1988; 
Seilheimer and Schachner, 1987). In the peripheral nervous 
system, cytotactin (Daniloff et al.,  1989),  and J1/tenascin 
(Martini et al.,  1990)  are reexpressed in the regenerating 
adult sciatic nerve.  In the cerebral cortex, J1/tenascin  im- 
mtmoreactivity delineates the somatosensory barrel fields 
which have been proposed to be demarcated by transitory 
glial boundaries during the period of sensory afferent in- 
growth (Crossin et al.,  1989;  Steindler et al.,  1989a,b). 
Since J1/tenascin is expressed in the nervous system at crit- 
ical developmental time periods  and may occur both  in 
membrane-associated and soluble forms, we attempted to in- 
vestigate the influence of both forms of Jlttenascin on neu- 
ronal differentiation. To this aim,  central nervous system 
neurons were cultured at low density on J1/tenascin adsorbed 
to polyornithine-coated plastic or on different substrates in 
the presence of soluble J1/tenascin,  and neurite outgrowth 
and cell body spreading were analyzed morphometrically. 
We show here that J1/tenascin  promotes neurite outgrowth 
and elongation when used as substrate, but that it inhibits 
neurite extension on all substrates tested when added to the 
culture medium in soluble form. We localize a neurite out- 
growth-promoting region on the molecule and propose that 
it is different  from the cell-binding site for fibroblasts (Spring 
et al.,  1989) and not involved in inhibition of neurite out- 
growth and cell body spreading. 
Materials and Methods 
Animals 
FOr the preparations of single ceils from embryonic brains, CDI rats were 
used.  The day a vaginal plus was found was designated embryonic day 0 
(E0). 
Analytical Procedures 
Protein concentrations were measured according to Bradford (Bradford, 
1976). SDS-PAGE was performed on 4-10~ gradient slab gels (Laemmli, 
1970). The gels were stained with reducing silver ions (Merril et al., 1982). 
Antibodies 
The rat monoclonal IgG antibodies J1/tnl and Jl/tn2 against Jl/tenascin have 
been described (Faissner and Krnse, 1990;  Steindler et al.,  1989a;  Stern 
et al., 1989). The hybridoma clones were grown in RPMI 1640 containing 
Nutridoma (Boehringer Mannheim Biochemicals, Indianapolis, IN) and 
used as concentrated supernatants.  SDS-PAGE revealed a purity of >95 % 
of the antibodies. Polyclonal  antibodies to neural cell adhesion molecule 
(N-CAM) (Trotter et al., 1989) were a kind gift of Dr. J. Trotter and perox- 
idase-coupled  secondary antibodies to rabbit IgG were purchased from 
Cappel  Laboratories (Cochranville, PA). 
ECM Molecules 
Human serum fibronectin and the GRGDS peptide were purchased from 
Boehringer Mannheim Biochemicals.  Laminin isolated  from Engelbreth- 
Holm-Swarm  mouse sarcoma cells (Timpl et ai.,  1979) was a kind gift of 
Dr. K. Kfi.hn  (Max-Planck-Institut  fiir Biocbemie, Martinsried, Germany). 
J1/tenascin was immunoaffinity purified on Jl/tnl and Jl/tn2 columns from 
detergent-free  extracts of brains from zero- to 15-d-old mice (I-Ioffman et 
al., 1988; Faissner and Kruse, 1990). Human tenascin was prepared from 
supernatants of the U-251MG  glioma cell line (Vanghan et al.,  1987). 
Preparation of  Substrates 
Cells were grown in 8-weU tissue culture plastic chamber slides  (Nunc, 
Roskilde,  Denmark; 0.8 cm2/well).  For preparation of coated substrates, 
culture dishes were incubated for 1-2 h at 37°C with 1.5 t~g/ml poly-DL- 
ornithine (Sigma Chemical Co., St. Louis, MO) in 0.1 M borate buffer, pH 
8.2. The wells were washed twice with distilled water, air dried, incubal~l 
overnight at 37"C with PBS, pH 7.4 (PBS;  100/~l/well) or PBS containing 
50 ttg/rnl Jl/tenasein, laminin, or fibronectin, sterilized by passage through 
filters  with low  protein binding capacity  (Millex  GV4;  Millipore/Con- 
tinental Water Systems, Bedford, MA), and finally washed twice again with 
PBS.  The efficiency of J1/tenascin adsorption to the polyornithine-coated 
culture dishes was determined by addition of 12~I-labeled  J1/tenascin (Faiss- 
her et al.,  1990) as tracer to the coating solution.  Under the conditions of 
this study, 22% (1.1 ttg) of the added J1/tenascin adsorbed to the bottom of 
the well. Of the adsorbed J1/tenascin 5 % (0.1 #g) was found to be released 
into the culture medium during the following 24-h culture period. 
Cell Culture 
Hippocampai cell cultures were established from EI8-E19 rat brains (Banker 
and Cowan,  1977) with some modifications.  Hippocampi were obtained by 
microdissection,  placed in Ca- and Mg-free  (CMF)  HBSS,  freed  from 
meninges  and incubated in CMF-I-IBSS containing 0.25%  wt/vol trypsin 
(Gibco Laboratories, Grand Island, NY; Bethesda Research Laboratories, 
Gaithersburg,  MD) for 10 min at 370C. After three washes in CMF-HBSS, 
hippocampi were dissociated by trituration in CMF-HBSS containing 1 mM 
Mg2SO4 and 0.025 % wt/vol  DNase I (Boehringer Mannheim Bit)chemi- 
cals) using fire-polished Pasteur pipettes. The resulting cell suspension was 
centrifuged  at 80 g for 10 min at room temperature and the pellet resus- 
pended in chemically defined medium (Rousselet et ai.,  1988; but without 
putrescine)  consisting of DME/F12  (1:1; Gibco Laboratories,  Bethesda 
Research  Laboratories) 2.4 mg/ml NaHCO3,  33 mM D-glucose,  2 mM 
L-glutamine,  25/~g/ml insulin, 100/~g/ml transferrin, 2  x  10  -8 M pro- 
gesterone,  3  x  10-sM selenium, 0.1% (wt/vol) ovaibumin,  5 mM Hepes, 
5 IU/ml penicillin, and 5/~g/ml streptomycin.  Monolayer cultures from sin- 
gle cell suspensions from mesencephalon and striatum were prepared from 
EI4-E15 and E15-E16 rats, respectively, and plated in defined medium (Cha- 
mak and Prochiantz, 1989). 90% of the mesencephalic and 98% of the hip- 
pocampal  cells were viable as judged by trypan blue exclusion.  All cells 
were plated at a density of 10,000 cells/cm  2 in 250 td medium per well and 
maintained in this medium for 24 h. The plating efficiency of hippocampal 
neurons 1.5 h after plating was "~70% on polyoruithine alone and on polyor- 
nithine with substrate-bound J1/tenascin. Under both conditions 24 h after 
plating the number  of cells attached to the culture substrate was only slightly 
decreased to about 65 %. Viability of cells as determined by trypan blue ex- 
clusion after 24 h of culture was 60% on polyornithine alone and 80% on 
polyornithine with substrate-bound Jl/tenascin, laminin,  or  fibroneetin. 
Cultures  of both hippocampal and mesencephalic cells were estimated  to 
be 98% pure neurons by morphological (Banker and Cowan,  1977; for hip- 
pocampal cultures)  or immunological  (Chamak and Proehiantz, 1989; for 
mesencephalic cultures) criteria. Cells were also cultured  in the presence 
of J1/tenascin,  antibodies to J1/tenascin,  or GRGDS  peptide (Boehringer 
Mannheim). The proteins were dialyzed against DME/F12 and sterilized by 
filtration (Millex GV4; Millipore/Continental Water Systems) before addi- 
tion to the cultures 1 h after cell plating at final concentrations of 15 and 
60 #g/ml, and 2 mg/ml, respectively, unless otherwise indicated.  For some 
experiments J1/tenascin was heat inactivated by boiling for 10 min. To test 
the influence of mAbs on the effects of substrate-bound  J1/tenascin, the wells 
were blocked for 2 h at 37°C  with 0.5 mg/ml heat-inactivated  (5 rain at 
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60/~g/ml of antibodies in PBS, and finally washed twice with PBS before 
cell plating. An equal concentration of antibodies was added to the culture 
medium 1 h after plating. When antibodies were tested for their influence 
on soluble J1/tenascin, they were incubated together with soluble Jl/tenascin 
for 2 h at 37°C and added to the cultures 1 h after call plating at final concen- 
trations as indicated for the individual components. Addition of soluble 
J1/tenasein did not detach the cells from their substrate. Neither soluble 
J1/tenascin nor antibodies affected  the survival rate of  hiPlxw,  ampal neurons. 
To determine how much of the soluble J1/tenascin in the culture medium 
remained in  solution or was  adsorbed to  the  substrate,  125I-labeled J1/ 
tenascin was  added as  tracer  to  the culture medium.  75%  (2.8  /zg) of 
J1/tenascin remained in solution, 16% (0.6/zg) adsorbed to the bottom and 
9% (0.3/~g)  to the wall of each well after a 24-h culture period. To evaluate 
whether a selection for particular neuronal cell types occurred on the differ- 
ent substrates and under the different culture conditions, hippocampal cells 
were first maintained for 24 h in defined medium, detached from the sub- 
strate by incubation with 0.05 % wt/vol trypsin and 5 mM EDTA in CMF- 
HBSS for 5 rain at 37°C, collected by centrifugation, and maintained for 
another 24 h under different culture conditions. 
CeU-Substrate Adhesion Assay 
To test the influence of II/tenascin on cell-substrate adhesion, 4,000 hip- 
pocampal neurons were plated in 20/~1 of chemically defined medium per 
well in Terasaki dishes (Nunc) and cultured as described above on polyor- 
nithine  (control),  on  substrate-bound J1/tenascin or in the presence of 
J1/tenascin added to the culture medium immediately after plating. After 
2 or 24-h incubation dishes were flicked upside down on a solid support 
covered with paper towel and washed once with 25/~1 chemically defined 
medium per well. Subsequently, residual cells were fixed and stained with 
toluidine blue as described below. Results were quantified by counting the 
number of cells attached to the flat bottom of individual Terasaki wells. 
When no mechanical shearing forces were applied, the plating efficiency af- 
ter 2 h  was 679  +  61.7 ceils (n =  6) under all conditions. 
Histo- and Immunochemical Staining 
of Cultured Cells 
For histochemical staining, cultures were fixed in PBS containing 2.5 % 
(vol/vol) glutaraldehyde for I h at room temperature. After two washes with 
PBS, cells were stained for 15 mln with 0.5 % (wt/vol) toluidine blue (Sigma 
Chemical Co.) in 2.5% (wt/vol) Na2CO3,  washed twice with distilled wa- 
ter, and air dried. FOr immunochemical staining, cultures were fixed with 
4 % paraformaldehyde in PBS for 15 rain at room temperature, washed twice 
with PBS, and blocked for 10 rain with 10% (vol/vol) horse serum in PBS. 
Cultures were then incubated for 30 min at 37"C with polyclonal N-CAM 
antibodies (1:200)  in PBS containing 10%  (vol/vol) horse serum, washed 
twice with PBS, and incubated for 30 min at 37"C with horseradish peroxi- 
dase-coupled secondary antibodies to rabbit IgG (1:1000) in PBS contain- 
ing 10% (vol/vol) horse serum. Subsequently, the cells were washed twice 
with PBS, incubated with 0.5 mg/ml diaminobenzidine, 0.015 % (vol/vol) 
1-1202 in  10 mM Tris-HC1,  pH 7.4,  at room temperature,  washed twice 
with distilled water, and then air dried. 
Morphometry and Statistical Analysis 
For quantitative morphometry only singly growing cells were measured and 
only neurites exceeding  one cell diameter in length were taken into account. 
Process bearing cells were determined as the fraction of at least 100 cells 
per well chosen at random and given in percent. Neurons extending pro- 
cesses were analyzed by evaluating the number of neurites and total length 
of neurites per cell and the surface area of the cell body. For determination 
of the time course of neuronal spreading, process bearing neurons as well 
as neurons without processes were analyzed. Surfaces and process lengths 
were measured using an Ai Tectron image analysis system (VIDS 111 soft- 
ware, Bestobell Mobrey CanbH, 4000 Dfisseldorf, NRW, Germany). Sam- 
pies of 50 randomly selected neurons were investigated per well. Since the 
single values obtained were not normally distributed, values of 50 neurons 
were summed up to apply a parametric comparison test among means for 
the determination of significance levels. The summed values exhibited nor- 
mality, according to the G-test for goodness of fit and homoscedastieity 
according to the Bartlett's test of  homogeneity, thus allowing statistical eval- 
uation with a parametric planned comparison test (least significant differ- 
ence- or LSD-test). Neurite lengths of  individual neurons were additionally 
analyzed with the ehl-squar¢ test for goodness of fit by grouping measure- 
ments obtained from single neurons into classes of equal length. In some 
cases, classes were lumped to obtain a theoretical frequency of  at least three. 
The Williams' correction was applied to reduce the type I error. All statisti- 
cal tests were taken from Sokal and Rohlf (1981). Plus/minus values appear- 
ing in the text or figure legends represent the respective SD. Graphical rep- 
resentations of  results were performed on a MAC II PC using the programs 
Statviow II TM (Abascus Concepts Inc., Berkeley, CA), Cricket Graph TM 
(Cricket Software, Malvern, PA), and Canvas TM (Deneba Software Inc., 
Miami, FL) at the ZMBH, University of Heidelberg. 
Rotary Shadowing and Localization of  Epitopes by EM 
EM was performed as described (Vaughan et al., 1987).  All samples were 
dialyzed against several changes of 0.2 M  ammonium bicarbonate before 
use and were mixed to give final concentrations of 10-50/zg/ml antibodies 
and 50/~g/ml Jl/tenasein. After incubation for 1-4 h at room temperature, 
each sample was diluted 2:1 (vol/vol) with glycerol, vortexed, and sprayed 
onto the surface of a freshly cleaved mica chip. Chips were affixed to the 
rotating  stage  of a  freeze-fracture unit  (model  BAh300;  Balzers  AG, 
Lichtenstein), dried under a vacuum of better than 10  -7 T  for 4-6 h  and 
shadowed with platinum/carbon at 7  a followed by a backing film of carbon 
at 90*.  Electron micrographs were obtained with an Hitachi S-600 elec- 
tron microscope and calibration was by means of  negatively stained catalase 
crystals. The curvilinear lengths of  hexabrachion arms from the T-junctions 
to the center of the distal knob and the antibody-binding sites were mea- 
sured with a graphics tablet interfaced with the Kontron IBAS graphics sys- 
tem (Kontron Elektronik GmbH, Ziirich, Switzerland). 
Figure L  SDS-PAGE of purified laminin, fibronectin, and J1/tenas- 
cin.  Laminin (lane 1),  fibronectin (lane 2),  and Jl/tenasein (lane 
3),  each at 2/zg, were resolved on a  4-10%  polyacrylamide gra- 
dient slab gel under reducing conditions. Protein bands were visual- 
ized by the reducing silver method. Molecular weight markers are 
indicated (180 k.D,  ct2-macroglobulin;  116 kD, ~galactosidase,  84 
kD,  fructose 6-phosphate kinase). 
Lochter et al. Jl/tenascin  Modulates Neurite Outgrowth  1161 Figure 2. Morphology of hippocampal neurons cultured on substrate-bound Jl/tenascin. Bright-field micrograph of hippocampal neurons 
cultured for 24 h on polyornithine (A, control), or J1/tenascin adsorbed to polyornithine-coated plastic in the absence (B) or presence of 
mAbs JlJtn2 (C) or Jl/tnl (D). Cells were stained with N-CAM antibodies by indirect immunoperoxidase. Typical process-bearing neurons 
are marked by arrows. Note the elaboration of single long axonlike processes in B and D (double arrowheads) as compared to the short 
ones in A and C (arrowheads). Bar, 20 #m. 
Results 
Substrate-bound J1/tenascin Promotes 
Neurite Extension 
The influence of  J1/tenascin on neurite extension was studied 
by maintaining hippocampal neurons at low density on de- 
fined substrates  under serum-free conditions.  In most ex- 
periments, cells were processed for morphometric analysis 
24 h after plating, after which time 50 % of the hippocampal 
neurons had  developed processes on polyornithine-coated 
plastic,  the  control  substrate.  Of these  neurons  80%  ex- 
hibited 1--4 and 20%  5-10 neurites. To study the effects of 
J1/tenascin on neurite outgrowth on polyornithine, J1/tenas- 
cin was isolated from postnatal mouse brain. These prepara- 
tions consisted of two major glycoproteins of 225 and 240 
kD migrating ahead of fibronectin in 4-10% gradient gels, 
as described (Faissner and Kruse,  1990; Fig.  1, lanes 2 and 
3). Hippocampal neurons grown on Jl/tenascin adsorbed to 
polyornithine-coated plastic  (substrate-bound  J1/tenascin) 
exhibited a more elaborate morphology than on polyornithine 
alone (Fig. 2, A and B). The fraction of  process-bearing ceils 
and their total neurite length were increased by ,,040% on 
substrate-bound J1/tenascin when compared to the control 
(Fig.  3).  These effects of the  substrate-bound  J1/tenascin 
were largely abolished by boiling the molecule before coat- 
ing (not shown). Neurons cultured in the presence of  the pen- 
tapeptide  GRGDS,  which blocks  the  interaction between 
integrins and some ECM molecules (Ruoslahti and Piersch- 
bacher,  1987),  were not modified in  their outgrowth be- 
havior on control or J1/tenascin substrates (not shown). Two 
mAbs against J1/tenascin, J1/tnl, and J1/tn2,  were tested for 
interference with the effects of substrate-bound J1/tenascin. 
J1/tn2  strongly decreased outgrowth and elongation of neu- 
rites  on  substrate-bound  J1/tenascin  (Figs.  2  C  and  3), 
whereas J1/tnl  did not significantly affect neurite extension 
(Figs. 2 D and 3). When neurite lengths on the control sub- 
strate or on substrate-bound J1/tenascin were compared in 
cumulative frequency distribution plots, they were continu- 
ously shifted to higher values on substrate bound J1/tenascin 
(Fig. 4), suggesting that all neurons responded to J1/tenas- 
cin.  J1/tn2  shifted  the  distribution  of neurite  lengths  on 
substrate-bound J1/tenascin to control values, whereas J1/tnl 
did not significantly alter it. Although routinely used at con- 
centrations of 60 #g/ml, J1/tn2 still strongly interfered with 
the stimulatory properties of substrate-bound J1/tenascin at 
10 #g/ml, whereas J1/tul did not show any effects when ap- 
plied even at concentrations of 250 #g/ml (not shown). Nei- 
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Figure 3. Effect of substrate-bound J1/tenascin on the morphologi- 
cal differentiation  of cultured hippocampal neurons. Hippocampal 
neurons were maintained on polyornithine-coated plastic (control), 
or J1/tenascin adsorbed to polyornithine-coated plastic  in the ab- 
sence (=) or presence of mAbs J1/trt2 (o) or J1/tnl (~a). After 24 h 
control values were for the fraction of  neurons with at least one neu- 
rite 48 + 3.2 %. Control values for the total number of  neurites (187 
-t- 28.4), total length of neurites  (4,795  4- 608 #m), and cell body 
area (7,635 4- 1,059.1/~m  2) were determined in duplicate  for sam- 
ples of 50 process-bearing neurons per culture well. Columns rep- 
resent the percent increase or decrease over control values and were 
calculated  as ([parameter==-parameteroo,~od/parameter~ol)  x  100. 
500 neurons (two wells with 50 neurons from five independent  ex- 
periments)  were  analyzed for each value,  except  for substrate- 
bound J1/tenascin in the presence of monoclonal J1/tnl antibodies 
where 300 neurons (two wells with 50 neurons from three indepen- 
dent experiments) were analyzed. Significance levels according to 
the LSD- and ehi-square tests are indicated  by the following sym- 
bols: (***) P ~  0.001; (**) 0.001 <  P ~< 0.01; (*) 0.01 <  P ~< 0.05; 
(ns) not significant.  Symbols above the columns refer to difference 
from the control and symbols below the columns refer to differences 
from substrate-bound J1/tenascin. 
ther  J1/tnl  nor J1/tn2  modified  neuron  attachment  to and 
neurite extension on the control substrate when used at con- 
centrations up to 250 #g/ml (not shown). 
Soluble J1/tenascin Inhibits Neurite Extension  ..... 
When added to the culture medium 1 h after cell plating on 
the control substrate, soluble J1/tenascin retarded neurite ex- 
tension from hippocampal neurons (Fig. 5).  The effect was 
concentration dependent with a tendency to saturation ob- 
servable at 15/zg/ml, the amount of J1/tenascin used for all 
further experiments (not shown). The proportion of process- 
bearing  cells,  total  number  of neurites  and  total  neurite 
length were significantly reduced in the presence of soluble 
J1/tenascin  (Fig.  6).  A  cumulative  frequency  distribution 
plot  indicates  that  neurite  lengths  were  evenly  shifted  to 
lower values (not shown). J1/tnl and J1/tn2 did not neutralize 
the inhibitory properties of soluble J1/tenascin on neurite ex- 
tension when used at 60 or 250/zg/ml.  In contrast,  when 
J1/tenascin was boiled for 10 min, the inhibitory properties 
of soluble J1/tenascin were largely abolished (Fig. 5  C and 
not shown). 
of cultured hippocampal neurons.  Cumulative frequency distribu- 
tion plot of the percentage of hiptxmampal  neurons (ordinate)  with 
neurites  longer than a given length in/zm (abscissa)  on the control 
substrate  (e) and substrate-bound  JVtenascin in the absence (I) or 
presence of m.Abs J1/tnl  (D) or J1/tn2 (o).  Individual values  are 
from 100 neurons in two wells for each condition taken from one 
representative  experiment. 
Inhibition  of  neurite  outgrowth  by  soluble  JlJtenascin 
could not be detected within the first 12 h after cell plating 
on the polyornithine substrate.  0.5,  1.5, 4.5, and  12 h after 
plating 5 +  0.5, 6 +  0.7, 7 +  1.4, and36 +  3.8% ofneurons, 
respectively, had developed neurites in the absence of solu- 
ble J1/tenascin, while 1.5, 4.5, and 12 h after plating 8 +  1.7, 
12 +  2.0, and 34 d: 7.4% of neurons, respectively, had devel- 
oped processes  on polyornithine when  soluble J1/tenascin 
was added to the cultures 1 h after plating. It is noteworthy 
that a lag phase of at least 4.5 h in neurite outgrowth on poly- 
ornithine in the absence or presence of soluble J1/tenascin 
could not be detected on substrate-bound J1/tenascin where 
0.5,  1.5, 4.5, and 12 h after cell plating 14  -1-  1.7, 26  -1-  1.7, 
38  +  2.3,  and  68  +  3.0%  of neurons,  respectively,  had 
grown out neurites.  Each value was derived from 300 neu- 
rons of two independent experiments. 
To exclude that the effects of J1/tenascin were because of 
preferential substrate adherence of a  subclass of hippocam- 
pal neurons under different culture conditions, the following 
experiment  was  carded  out:  hippocampal  neurons  were 
maintained for 24 h on the control substrate in the absence 
or presence of soluble J1/tenascin  and on substrate-bound 
J1/tenascin. Ceils were then gently removed from these sub- 
strates and further cultured for 24 h by switching substrates 
(Table  I).  The  effects  of substrate-bound  and  soluble  J1/ 
tenascin appeared completely reversible in that neurons first 
grown on substrate-bound J1/tenascin and then subcultured 
on the control substrate, on substrate-bound J1/tenascin or in 
the presence of soluble J1/tenascin  responded  in the same 
manner as freshly dissociated cells. Similar results were ob- 
tained when the cells were first cultured under control condi- 
tions or in the presence of soluble J1/tenascin  (Table I). 
The inhibitory properties of soluble J1/tenascin were not 
dependent on the culture substrate. When hippocampal neu- 
rons were grown on substrate-bound laminin, fibronectin, or 
Lochter et al. J1/tenascin  Modulates Neurite  Outgrowth  1163 Figure 5.  Morphology of hippocampal neurons cultured in the presence of soluble J1/tenascin.  Bright-fieM micrograph of hippocampal 
neurons cultured for 24 h on polyomithine (.4), control or on polyornithine in the presence of soluble J1/tenascin (B), heat-inactivated 
soluble ll/tenascin  (C), or soluble J1/tenascin in the presence of monoclonal  Jl/tn2 antibodies (D). Cells were stained with toluidme blue. 
Typical process-bearing neurons are marked by arrows. Note the retarded development  of process-bearing neurons in B and D as compared 
to A and C. Bar, 20 #m. 
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Figure 6. Effect of soluble Jl/tenascin on the mor- 
phological differentiation of cultured hippocampal 
neurons. Hippocampal  neurons were maintained 
on polyorrtithine (control), on polyomithine-coated 
plastic in the-presence  of soluble Jl/tenascin (i), 
or of soluble J1/tenascin in the presence of mono- 
clona[ II/tn2 ([]) or Jlltnl (~)  antibodies. After 
24 h, control values were for the fraction of neu- 
rons with at least one neurite 52 +  5.8 %. Control 
values for the  total number of neurites (196  + 
17.6), total length of neurites (4,890 +  687.5 #m), 
and cell body area (7,279 =t: 770.3 #m  2) were de- 
termined for samples of 50 process-bearing neu- 
rons per culture well. Columns represent the per- 
cent increase or decrease  over control values and 
were calculated as  ([pararneter~t  --  parameter~o,. 
t~d/parameter~o,~t) x  100. 400 neurons (four in- 
dependent experiments)  were  analyzed for each 
condition. Significance  levels  according to  the 
LSD- and chi-square tests are indicated by the fol- 
lowing symbols: (***) P g  0.001; (**) 0.001 < P 
0.01; (*) 0.01 < P g 0.05; (ha) not significant. Sym- 
bols above the columns refer to differences from 
the control and symbols below the columns refer 
to differences from soluble JUtenascin in the ab- 
sence of antibodies. 
The Journal of Cell Biology, Volume 113, 1991  1164 Table L Effect of  Soluble and Substrate-bound 
J1/tenascin on Neurite Outgrowth from Cultured 
Hippocampal Neurons on Switched Substrates 
Condition for the first 24 h 
Condition for the 
second 24 h  Control  bTN  sTN 
Control  4,665  4,295  4,870 
bTN  6,040  ***  5,475  ***  6,180  *** 
sTN  2,645  ***  2,230  ***  2,890  *** 
HiPlx~campal neurons were maintained for 24 h under three different culture 
conditions as indicated.  Cells were then trypsinized and maintained for another 
24 h on switched substrates as indicated.  Total neurite lengths of 50 neurons 
from one representative experiment are shown. Significance levels indicated in 
each column are related to differences from the control value of the respec- 
tive column. Significance levels according to the chi-square test are indicated 
by  ***, P  ~  0.001.  (bTN)  Substrate-bonnd J1/tenascin;  (sTN)  soluble J1/ 
tenascin. 
J1/tenascin (preparations are shown in Fig.  1), addition of 
soluble J1/tenascin resulted in a  decrease of total neurite 
length  in  all  cases  (Table II).  Furthermore,  neurons  dis- 
sociated from mesencephalon and striatum showed similar 
responses to soluble and substrate-bound J1/tenascin as hip- 
pocampal neurons (not shown). 
Substrate-bound and Soluble Jl/tenascin Inhibit 
Spreading of Neuronal Cell Bodies and Decrease 
Neuron-Substrate Adhesion 
The spreading of neuronal cell bodies was reduced by ~30% 
on substrate-bound J1/tenascin or in the presence of soluble 
J1/tenascin (Figs. 3 and 6). To further investigate this phe- 
nomenon and to examine whether a  correlation exists be- 
tween spreading of neuronal cell bodies and their ability to 
Table I1. Effect of  Soluble J1/tenascin  on Neurite Lengths 
of Cultured Hippocampal Neurons on Substrate-bound 
J1/tenascin,  Laminin, and Fibronectin 
Significance 
Total neurite length of  Compared  Compared 
Condition  50 neurons in t~m +  SD  to control  to ECM 
Control  2,794  +  234.1 
bTN  5,850  5:208.7  *** (***) 
to bTN 
bTN  +  sTN  3,495  +  139.6  *  (***)  *** (***) 
bLN  5,280  ±  494.9  *** (***) 
to bLN 
bLN  +  sTN  3,308  ±  188.8  NS  (*)  *** (***) 
bFN  4,104  ±  181.8  *** (***) 
to bFN 
bFN  +  sTN  3,308  ±  188.8  NS  (NS)  *  (***) 
Hippocampal neurons were maintained for 24 h on different substrates in the 
absence or presence of soluble J 1/tenascin as indicated in the first column. To- 
tal neurite lengths of 50 neurons from two culture wells each were determined 
in three independent experiments. Significance levels according to the LSD- or 
chi-square tests are indicated, with the results of the latter put in parentheses, 
and were related to differences to the polyornithine control substrate or, in 
cases where soluble Jl/tenascin was present, to the ECM-substrate in the ab- 
sence of soluble J 1/tenascin. Significance  levels are indicated by the following 
symbols: (***), P g  0.001; (**), 0.001  <  P g  0.01; (*) 0.01  <  P g  0.05. 
(b/N) Substrate-bound J1/tenascin; (bTN +  sTN) substrate-bound Jl/tenascin 
in the presence of soluble J 1/tenascin; (bLN) substrate-bound laminin; (bLN + 
s/N) substrate-bound laminin in the presence of soluble J1/tenascin; (bFN) 
substrate-bound fibronectin;  (bFN + s/N) substrate-bound fibronectin in the 
presence of soluble Jlttenascin; (ECM) extracellular matrix substrate. 
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Figure  7.  Time course of cell body spreading in the presence and 
absence of J1/tenascin. Hippocampal neurons were maintained on 
polyornithine  in the absence (control,  e)  or presence of soluble 
J1/tenascin added during ([])  or  1 h  after  (o)  cell plating,  or on 
substrate-bound J1/tenascin (,,).  Mean values of cell body surface 
areas  (ordinate)  are  semilogarithmically plotted  as  a  function of 
time after cell plating (abscissa). For each value 300 neurons (six 
wells  with  50  neurons from two  independent experiments)  were 
analyzed.  Mean values  +  SD  are  shown.  All values are  signifi- 
cantly different from the control according to the LSD- and chi- 
square tests (P ~< 0.001). 
extend neurites,  spreading of cell bodies of hippocampal 
neurons was investigated under the same conditions as neu- 
rite extension. On the polyornithine substrate, the surface 
area of the cell body increased continuously during the first 
4.5 h after plating (Fig. 7). After 12 and 24 h the surface area 
was decreased by :,,20%,  when compared to the value at 
4.5 h. When J1/tenascin was added to the culture medium 
1 h after cell plating on polyornithine, the initial spreading 
of the cell body seen at 4.5 h was reversed. When the cells 
were plated on substrate-bound J1/tenascin or on polyorni- 
thine in the presence of soluble J1/tenascin cell spreading was 
strongly impaired at all time points tested (Fig. 7). Because 
of the inclusion of nonprocess-bearing cells, the overall sur- 
Table IlL Effect of  J1/tenascin 
on Neuron-Substrate  Adhesion 
Number of cells +  SD 
Condition  2 h  24 h 
Control  384  +  42.9  341  +  43.6 
bTN  31  -t-  16.2  15  +  11.0 
sTN  41  +  18.1  27  +  10.4 
Hippocampal neurons were grown in Terasaki dishes on polyornithine-coated 
plastic (control), substrate-bound J1/tenascin (bTN),  or in the presence of 
Jl/tenascin added to the culture medium directly after plating (sTN). After 2 
or 24 h of incubation cells were subjected to mechanical forces and the residual 
neurons attached to the substrate were counted. 18 wells from three indepen- 
dent experiments were analyzed for each condition and one Terasaki dish was 
used per time point and experiment for all treatments. According to the LSD- 
test the values obtained for bTN and sTN differ significantly (P < 0.001) from 
the polyornithine control values. 
Lochter et al. J1/tenascin Modulates Neurite Outgrowth  1165 Figure 8. Analysis of antibody binding domains of ll/tenascin molecules by rotary shadowing.  J1/tenascin  from mouse brain (,4, B, and 
C) or human glioma (D) was incubated with rnAbs Jl/tn2 (B and D) or Jl/tnl (C). In A a variety of typical oligomers extracted and purified 
from mouse brains is shown.  In B and D the J1/tn2 epitope is indicated  by arrowheads and in C that of Jl/tnl by arrows.  Both antibodies 
frequently  cross-linked  adjacent  J1/tenascin polypeptides.  Bar,  100 nm. 
face covered by the neurons was found increased,  as com- 
pared  to the analysis of neurite-growing cells  alone.  This 
might reflect the formation of veil-like lamellipodia by many 
neurons  without processes.  To  investigate  implications  of 
the anti-spreading effect of J1/tenascin its influence on neu- 
ronal  substrate  adhesion  was  determined.  When  neurons 
were plated on substrate-bound Jl/tenascin or in the presence 
of the  soluble molecule,  the vast majority  (•95%)  of the 
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Figure 9. Histograms of antibody 
binding  site distributions.  Num- 
ber  of measurements  (ordinate) 
plotted  against  the  curvilinear 
length of the arms from the T-junc- 
tion  to the  center  of the  distal 
knob  (abscissa)  for  J1/tenascin 
from mouse (a) and human (d). 
The position of the J1/tnl epitope 
as  measured  from  the  T-junc- 
tion (black) or the distal domain 
(hatched) is shown in c for mouse 
J1/tenascin.  The  corresponding 
position  of the Jl/tn2  epitope  is 
shown in b and e for the mouse 
and  human  molecules,  respec- 
tively. A diagrammatic represen- 
tation  of the  epitopes  for J1/ml 
(1) and J1/tn2 (2) is shown. Both 
mouse  and  human  preparations 
contain  a  mixture  of isoforms, 
resulting  in a broad distribution 
of values encompassing the vari- 
able spliced region of the type III 
homology domains. 
ceils could be detached from the bottom of Terasaki wells 
by mechanical forces which left ~50% of the neurons on the 
polyornithine control (Table HI), indicating a reduction of 
neuronal substrate attachment forces. 
Localization of  Antibody Binding Sites on J1/tenascin 
Electron micrographs of rotary shadowed J1/tenascin from 
mouse brain revealed monomers and a variety of oligomers 
ranging from dimers to hexamers (Fig. 8 A). The lengths of 
the arms from the T-junction to the center of the distal knob 
(fibrinogen homology domain), including the thin proximal 
portion (EGF-like repeats) and the thickened distal region 
(fibronectin type III homology repeats) were measured (Fig. 
9) and are listed in Table IV. The corresponding lengths for 
J1/tenascin from the human glioma cell line U 251  MG are 
listed for comparison. The difference between mouse and 
human in the length of the type III homology regions of 10 
nm  corresponds  to  a  difference of two to  four  domains. 
Mouse J1/tenascin was incubated with J1/tnl and both mouse 
and human J1/tenascin were incubated with the species cross- 
reactive  antibody  J1/m2.  Typical  examples  of J1/tenascin 
oligomers labeled with  the antibody are shown in Fig.  8. 
Arms were commonly cross-linked by the divalent antibod- 
ies. Both antibodies bound within the thickened distal portion 
of J1/tenascin which corresponds to the fibronectin type HI 
homology region (Spring et al., 1989; Kaplony and Vaughan, 
manuscript submitted for publication). For measurement of 
the antibody-binding sites,  only those which  were clearly 
depicted alongside, but still touching the arm, were chosen. 
The resultant distributions of J1/tnl and J1/tn2, measured for 
both the T-junction and the distal end, are shown in Fig. 9. 
The epitope for the J1/tn2  antibody is located 57  +  4  nm 
(n  =  53)  from the  T-junction  in  mouse and  70  +  6  nm 
(n  =  73) in human J1/tenascin.  The distances of the Jl/tn2 
epitope from the distal ends are 14  +  2 nm (n  =  53) and 
15 +  3 nm (n =  76) in mouse and human, respectively. Sub- 
tracting the contributions of the distal knobs leaves in both 
cases a distance of 12 +  3 nm into the type HI region, mea- 
sured from the distal end. Antibody J1/tnl binds 47 +  3 nm 
(n =  53) from the T-junction and 23 +  3 nm (n =  53) from 
the distal end of mouse J1/tenascin (Figs.  8 and 9). 
Table IV. Morphometric Analysis of  mAb Binding Sites 
on J l /tenascin from Mouse Brain and Human Glioma 
by EM of  Rotary-shadowed  Molecules 
Mouse  Human 
Whole arm  71  +  6nm(n  =  94)  85  +  6nm(n  =  106) 
EGF-repeatregion  27 +  3nm(n  =  55)  32  +  3nm(n  =  54) 
Type III repeats  43  +  4nm(n  =  55)  53  :i: 5nm(n  =  54) 
The average curvilinear length of the J1/tenascin arms from the T-junction to 
the center of  the distal knob is shown for mouse and human. The relative distri- 
bution of the thin proximal region (EGF-like repeats) and the thickened distal 
portion (fibronectin type III repeats), which includes the variable spliced region, 
are listed. 
Discussion 
Recent investigations have shown that tenascin-like mole- 
cules are poor substrates for the culture of  dissociated central 
or peripheral nervous system neurons plated under normal 
gravity conditions (Friedlander et al., 1988; Chiquet, 1989; 
Wehrle  and  Chiquet,  1990;  Faissner  and  Kruse,  1990). 
When  adsorbed to  a  favorable substrate  for neural  cells, 
polyornithine  (Collins,  1978),  J1/tenascin  shows repulsive 
properties for the attachment of CNS neuronal cell bodies 
without, however, inhibiting neurite outgrowth (Faissner and 
Kruse, 1990). This indicates that the molecule might modu- 
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neuronal differentiation. To investigate the influence of J1/ 
tenascin on the establishment of neuronal morphology, we 
have cultivated single embryonic rat CNS neurons in defined 
medium at low density on polyornithine-coated plastic sur- 
faces (control), on J1/tenascin adsorbed to the polyornithine 
substrate (substrate-bound J1/tenascin),  and in presence of 
J1/tenascin  added to the culture medium (soluble J1/tenas- 
cin). We propose three major inferences from our observa- 
tions: (a) a molecular domain inducing neurite outgrowth on 
substrate-bound J1/tenascin  involves the fibronectin type III 
homology repeats; (b) substrate-bound and soluble J1/tenas- 
cin affect neurite outgrowth in opposite ways, in that sub- 
strate-bound J1/tenascin promotes and soluble J1/tenascin in- 
hibits neurite outgrowth; and (c) spreading of neuronal cell 
bodies is reduced both by substrate-bound and soluble J1/ 
tenascin, probably by a molecular mechanism not involving 
the neurite outgrowth promoting domain of the molecule. 
J1/tenascin bound to polyornithine is a neurite outgrowth 
promoting molecule for neurons from hippocampus, mesen- 
cephalon,  and striatum.  This observation parallels recent 
results showing that tenascin adsorbed to polylysine fosters 
neurite  outgrowth by  embryonal chicken  sensory,  spinal 
cord, and sympathetic neurons (Wehrle and Chiquet, 1990). 
The neurite outgrowth promoting effect of J1/tenascin  was 
apparent shortly after cell plating, in contrast to the inhibi- 
tion of neurite outgrowth by the soluble molecule (see be- 
low). The neurite outgrowth promoting property was neu- 
tralized by the mAb J1/tn2 but not by the control antibody 
J1/tnl.  This indicates that the J1/tn2 epitope is functionally 
connected with or identical to a neurite outgrowth-inducing 
domain of the glycoprotein. Rotary shadowing analysis showed 
that the J1/tn2 epitope localizes to the fibronectin type HI 
repeats of J1/tenascin.  Assuming that a fibronectin type HI 
repeat of Mr 10,000 approximates a sphere with a diameter 
of 2.9 nm, the epitope for J1/tn2 is on the third or fourth re- 
peat from the distal, carboxyterminal end of the molecule 
which is marked by the fibrinogen knob. This would place 
the epitope in either repeat 12 or 13 in the human protein 
(Gulcher et al., 1989).  These repeats are homologous with 
the fibronectin type III repeats eight and nine of chicken 
tenascin (Spring et al., 1989). The epitope of the mAb Tn68 
that is involved in tenascin-induced hemagglutination of sheep 
red blood cells and binding of fibroblasts to chicken tenascin 
(Chiquet-Ehrismann et al., 1988; Spring et al.,  1989) is in 
a region of 104 amino acids within the tenth and eleventh 
fibronectin type HI repeats of chicken tenascin. J1/tenascin 
from mouse has  a  similar structural organization and its 
cDNA sequence displays substantial homology (Weller et 
al.,  1991) to the one reported for chicken tenascin (Spring 
et al.,  1989),  cytotactin (Jones et al.,  1989),  and human 
hexabrachion (Gulcher et al., 1989). Thus, distinct domains 
in the fibronectin type HI homology repeats seem implicated 
in cell attachment to and neurite outgrowth on substrate- 
bound J1/tenascin. 
Whereas substrate-bound J1/tenascin  promotes extension 
of neurites, soluble J1/tenascin  interferes with neurite out- 
growth.  In  this  respect  J1/tenascin  behaves  like  soluble 
cytotactin which inhibits the outgrowth of fiber bundles from 
embryonic chicken dorsal root ganglion explants at 10/~g/ 
ml, a concentration comparable to the one used in the pres- 
ent study (Crossin et al., 1990). This inhibitory property of 
J1/tenascin  could be observed with hippocampal, mesence- 
phalic, and striatal neurons plated on the polyornithine sub- 
strate alone, or on substrate-bound J1/tenascin,  laminin, or 
fibronectin. The opposite effects of J1/tenascin  on neurite 
outgrowth thus parallel results obtained with a  neuroblas- 
toma cell line for which substrate-bound tenascin increased 
and soluble tenascin slowed down the cellular migration rate 
(Halfter et al.,  1989).  The inhibitory effect of soluble J1/ 
tenascin was not affected by our mAbs, even when these were 
used in about 20-fold excess over the ECM constituent on a 
molar basis. The observation that J1/tn2 interferes with pro- 
motion and not with inhibition of neurite outgrowth could in- 
dicate differences in the molecular bases for promotion and 
inhibition of neurite extension by J1/tenascin.  This conten- 
tion is  supported by the observation that the mAb Tn68, 
which recognizes the cell-binding site of tenascin for fibro- 
blasts and binds to a region distinct from the J1/tn2 epitope 
(see above),  inhibits the reduction of neuroblastoma migra- 
tion rates by soluble tenascin (Halfter et al.,  1989).  It can 
at present,  however,  not be excluded that the inability of 
J1/tn2 to block the effects of soluble J1/tenascin  is a conse- 
quence of conformational transitions between the soluble 
and the  substrate-bound form of the glycoprotein. These 
putative conformational changes might attenuate-or even 
abolish-the neutralizing effect of  J1/tn2 binding on the func- 
tional properties of the molecule. Further, the multivalency 
of J1/tenascin might render it difficult to block its functional 
regions by antibodies in solution. The resolution of this issue 
will require the separate preparation of the different molecu- 
lar domains of the glycoprotein. 
The inhibitory effect of soluble J1/tenascin was concentra- 
tion dependent and sensitive to heat treatment. As control, 
the antibodies J1/tnl or J1/tn2 added to neurons growing on 
polyornithine or substrate-bound laminin and fibronectin in 
up to 20-fold higher concentration (on a molar basis)  than 
soluble J1/tenascin  did not affect neurite growth. The spe- 
cificity of the dual, opposite effects of J1/tenascin  is further 
supported by recent results obtained with other extracellular 
matrix components, l_aminin and fibronectin, molecules which 
also show neurite outgrowth promoting properties (for re- 
view see Sanes, 1989), have been described to influence the 
differentiation of mesencephalic neurons in vitro in different 
ways, depending on their mode of presentation. Soluble lami- 
nin and substrate-bound fibronectin induce a strongly polar- 
ized neuronal phenotype in which axonal is favored at the ex- 
pense of dendritic growth. Conversely, soluble fibronectin 
and substrate-bound laminin enhance expansion of the den- 
dritic compartment as compared to the growth of the axon 
(Chamak and Prochiantz,  1989;  Rousselet et al.,  1990). 
Based on experiments correlating neuronal spreading with 
adhesion the authors provided evidence that conditions of 
high adhesion (in case of substrate-bound laminin and solu- 
ble fibronectin) support dendritic whereas conditions of low 
adhesion (in  case of soluble laminin and substrate-bound 
fibronectin) promote axonal growth.  Further reduction of 
adhesion may ultimately lead to inhibition of  both axonal and 
dendritic growth. In this context it is noteworthy that sub- 
strate-bound J1/tenascin displays some polarizing activity by 
lengthening the axonlike longest process by 70%, but the 
dendritelike shorter processes by only 20 %, whereas soluble 
tenascin inhibits the elongation of both classes of processes 
to a  similar degree (our unpublished observations).  How- 
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duce the attachment of neurons to the culture substrate in a 
comparable manner (see below), the differential effects of  the 
molecule on process outgrowth appear not to be directly cor- 
related with the degree of cell adhesivity. 
Soluble Jl/tenascin inhibits neurite outgrowth on different 
substrates. Therefore, it is unlikely that the inhibitory effect 
of soluble J1/tenascin is because of the direct blocking of the 
cell surface receptors for laminln, fibronectin, or the sub- 
strate-bound form of J1/tenascin. The retardation of neurite 
outgrowth by soluble J1/tenascin becomes apparent after an 
incubation period of 12 h. This might indicate that J1/tenas- 
cin does not interfere with the initiation, but with the stabili- 
zation of neurites, a process known to involve the cytoskele- 
ton (Bray and Hollenbeck,  1988).  Tenascin has,  indeed, 
been suggested to interfere with cytoskeletai organization in 
fibroblasts, suppressing cell spreading on tenascin or mixed 
tenascin/fibronectin substrates (Chiquet-Ehrismann et al., 
1988; Lotz et al., 1989). It is likely that similar mechanisms 
hold true for neurons also. Explanations for the dichotomy 
in the effects of soluble versus substrate-bound J1/tenascin 
cannot be given at present, but it may be related to, although 
not exclusively caused by differences in presentation of the 
molecule as soluble versus substrate-bound ligand. 
Both soluble and substrate-bound J1/tenascin reduce the 
spreading of neuronal cell bodies. This is in accordance with 
the anti-spreading effect of tenascin for fibroblasts, neural 
crest derivatives and other cell types investigated so far (Tan 
et al., 1987; Mackie et al., 1988; Chiquet-Ehrismann et al., 
1988;  Friedlander et  al.,  1988;  Bourdon and  Ruoslahti,~ 
1989; Halfter et al., 1989; Riou et ai., 1990). The inhibitory 
influence of J1/tenascin on cell body spreading is probably 
responsible for the weaker attachment of neurons to the J1/ 
tenascin-coated polyornithine substrate which we observed 
in the present study. Under conditions of high cell density 
plating the reduction of cell-substrate adherence leads to the 
preponderance of cell-cell adhesion forces (Jessel,  1988). 
The aggregation of neurons and fasciculation of neurites on 
homogeneous and the preferential enrichment of neurons or 
neurites on J1/tenascin-free as compared to J1/tenascin-con- 
taming areas of patterned J1/tenascin/polyornithine (Faiss- 
ner and Kruse, 1990) or cytotactin/laminin (Crossin et al., 
1990)  substrates might hence be because of interference of 
J1/tenascin with neuron-substrate contact formation. The 
molecular domain of J1/tenascin responsible for inhibition 
of spreading appears not related to the J1/tn2-binding site 
involved in neurite outgrowth since this mAb does neither 
abolish the anti-spreading nor the repulsive effect of  J1/tenas- 
cin (this study; and Faissner and Kruse, 1990). It is notewor- 
thy that the antibody Tn68  neutralizes the anti-spreading 
effect of tenascin on fibroblasts (Chiquet-Ehrismann et al., 
1988),  underscoring that the antibodies Tn68 and J1/tn2 are 
functionally  distinct and recognize separate sites on the mol- 
ecule, in accordance with the conclusions drawn from our 
rotary shadowing studies. Recent investigations with fusion 
proteins have localized a cell-binding site to the carboxyter- 
minal and an anti-spreading domain to the aminoterminal 
half of tenascin. The mAb Tn68, which counteracts the anti- 
spreading effect of  the molecule, inhibits the binding of  fibro- 
blasts to the cell-binding fragment (Chiquet-Ehrismann et 
al., 1988, Spring et al., 1989). In this perspective, the inter- 
action of a cell with the cell-binding domain seems a prereq- 
uisite for the anti-spreading activity of  tenascin. Recent mea- 
surements of the adhesive forces developing between cells 
and tenascin compared with fibronectin have shown a func- 
tional dissociation of the initial binding event and cell spread- 
ing for fibroblasts (Lotz et al.,  1989). 
The molecular dichotomy relating to cell body spreading 
on the one hand and neurite outgrowth on the other hand is 
remarkable in view of the transducing signals presumably 
elicited  in  the  J1/tenascin-responsive  neurons.  Since  our 
study shows that these two mechanisms may be different, the 
challenging problem emerges of how cellular receptors can 
effect such compartmentalized communication with the cy- 
toskeleton that directs cell body spreading and neurite out- 
growth.  Bourdon and Ruoslahti (1989)  have reported the 
isolation of an RGD peptide-dependent integrin by affinity 
chromatography on a tenascin column. Yet, it is unlikely that 
RGD peptide-dependent integrins mediate any of the neu- 
ronal responses to J1/tenascin, since the GRGDS peptide did 
not interfere with the neurite outgrowth stimulating or in- 
hibiting properties of J1/tenascin  in our assay systems and 
since tenascin from mouse fibroblasts lacks the RGD motive 
(Weller et al.,  1991). Other receptor candidates have been 
described for J1/tenascin, including heparin (Marton et al., 
1989;  Faissner et al.,  1990)  and a chondroitinsulfate pro- 
teoglycan (Hoffman et al.,  1987, 1988). 
In conclusion, our study suggests that J1/tenascin is a mul- 
tifunctional molecule which exerts both inhibitory and stim- 
ulatory influences on neurite outgrowth depending on whether 
it is presented to the cell in substrate-bound or soluble form. 
In our view, it is plausible to assume that these different fea- 
tures involve at least two distinct functional domains, one 
that promotes neurite outgrowth and another (others) that in- 
hibit(s)  neurite outgrowth and/or substrate  attachment of 
neuronal cell bodies. It is tempting to speculate that the mul- 
titude of functional properties of J1/tenascin and its corre- 
sponding receptor mechanisms might be implicated in such 
different functional events as the establishment of barrel- 
field boundaries in the somatosensory cortex (Steindler et 
al., 1989a,b), patterns of neurite outgrowth in the develop- 
ing and regenerating peripheral nervous system (Martini and 
Schachner, 1991; Martini et al., 1990) and directing regrow- 
ing axons to the original synaptic sites at the denervated neu- 
romuscular junction (Sanes  et al.,  1986;  Daniloff et al., 
1989;  Gatchalian et al.,  1989).  The elucidation of the as- 
serted functional role(s) of  J1/tenascin in these events will re- 
quire the establishment of assay systems designed to reflect 
the more complex situations in vivo. 
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